Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • I, the submitting author, warrant that I have the permission of any and all co-authors to submit this manuscript, that any co-authors can be considered as such according to the Journal's authorship criteria and that I have permission to be their spokesperson during the review process and beyond. I also approve distribution with the CC license the journal uses, and this too has been approved by co-authors.
  • All authors of the manuscript are qualified to be considered as such, in accordance with the guidelines set forth in authorship criteria and all have given their permission to be listed in the submitted manuscript.
  • The manuscript has not been previously published in the current submitted version, nor is it under consideration by another journal. If the manuscript has been published in an earlier version, this should be clearly indicated; see the Journal's editorial guidelines. (Feel free to enter an explanation in the box "Comments to the editor" if relevant).
  • The submitting author has entered their ORCiD identification number in their author data. Any co-authors have been advised to also provide their ORCiD in accordance with the Journal's policy.
  • All material presented in the manuscript where copyright is held by third parties has been properly produced and necessary permissions have been obtained from the submitting author.
  • The text follows the stylistic and bibliographic requirements specified in the author instructions.
  • The manuscript files uploaded for review are anonymized according to the Journal's policy.
  • All individuals or groups of individuals who can be identified in a study, or their guardians, have signed informed consent documents, thereby giving their consent for the submitted manuscript to be published under a CC license.
  • Where applicable, the research has been reviewed by an appropriate ethics committee and the name of the committee and approval reference number included in the submitted manuscript.

Author Guidelines

Before submitting your manuscript to the JEVTM, please read the full Instructions for Authors and ensure the submission complies with all the points detailed in the checklist above .


Narrative Review Articles

  • This style of article can afford the author considerable latitude in examining a pertinent topic in endovascular hemorrhage control. The literature should be examined objectively and presented to the reader in the context of current understanding. The author should be able to synthesize a narrative, which leaves the reader with a good understanding of an emerging or controversial topic. The author is welcome (and encouraged) to express an opinion, but where this is the case, it should be clearly stated.
  • The submitted manuscript should be no longer than 5000 words. There is no formal structure; however, the use of logical headings/sub-headings is important to enable readers to follow the article easily. 
  • The abstract should also be unstructured and be a maximum of 150 words. 

Systemic Reviews and Meta-Analyses

  • Where there is a topic within the subject area of endovascular hemorrhage control that has a substantial evidence base, a Systematic Review with/without a Meta-Analysis is considered more appropriate than a narrative review article. These articles should follow the methodology established by PRISMA. The overall aim is to provide a pooled analysis that enables firm conclusions to be drawn on a particular subject. 
  • Submitted manuscripts should be no longer than 5000 words, and authors should include a PRISMA checklist in their submission. 
  • The abstract should be no longer than 250 words. 

Tips and Techniques

  • In the evolving world of endovascular hemorrhage control, the advice and opinion of actively practicing clinicians is of great importance. Both solicited and unsolicited submissions are reviewed, both on major or minor components of endovascular techniques. This can be presented in the context of “evidence” or just as an opinion. The use of quality images and diagrams is encouraged. This type of article permits the author to write from experience, rather than from the published literature. Articles explaining how to approach certain problems or how to accomplish certain maneuvers are welcomed.
  • The submitted manscript should be no longer than 1500 words.
  • The abstract should be unstructured and be a maximum of 150 words. 

Original Article

  • This is a report of a formal basic science or clinical research study.
  • Manuscripts reporting unique scientific studies should be no longer than 5000 words. They should consist of the following sections:

    : This should concisely present the background to the problem that the study hopes to answer. A hypothesis should be clearly stated.
    Methods: This section should be suitably detailed to permit replication of the study. The regulatory permissions for the study should also be detailed, e.g. Institutional Review Board, ethical committee etc, including a protocol/registration number. Where animal research has been undertaken, the institutional animal care and use guidelines that have been followed should be clearly stated.
    Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. Numerical results and P values should be reported to three decimal places.
    Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data.

  • They should contain a structured abstract with a maximum of 250 words. 

Images of Interest

  • The Journal accepts images of interest accompanied by a short commentary. The aim of this section is to demonstrate and illustrate an educational message, rather than just to demonstrate dramatic pathology. Images can be submitted as a multi-panel with a series of scans/photographs in order to support the message presented in the narrative.  
  • The submitted manuscript should be no longer than 250 words.
  • Abstracts are not included. 

Case Reports

  • These are short case reports including current literature reviews. 
  • The submitted manuscript should be no longer than 1500 words
  • An abstract can be included (under 150 words) but is not compulsory. 

Letters to the Editor

  • Letters to the Editor that comment on anything within the Journal can be submitted for publication.
  • Abstracts are not included.

EVTM-ST Section

  • The EVTM-ST Section will be a section of each JEVTM edition geared towards residents/fellows and education. The editors will invite one trainee to submit an interesting case report, and invite a reviewer to review and add a brief editorial. The editors should not be authors nor reviewers.
    The components of the section will include a standard case report presentation with figures of CT or angio or anything interesting and pertinent. The discussion should finish with a "what I learned" summary/bullet points for education purposes. The brief editorial by the reviewer is the final paragraph.
  • The submissions should be a maximum of 1500 words
  • An abstract can be included (under 150 words) but is not compulsory.

Privacy Statement

The Journal will manage the users' names and email addresses registered for this website exclusively for academic purposes. Personal information will not be made available for any other purpose or to any other party. Read the JEVTM's full Privacy Policy here.